Delayed puberty
Pubertal development delay is also called delayed menarche. About 1% of girls do not have menstruation at the age of 18, but gradually mature later, so it is difficult to define development delay. At present, it is inclined to define development delay or primary amenorrhea when there is no sexual development at the age of 16 or no menstruation at the age of 18.
Related Drugs
Testosterone Propionate Injection
Indication: (1) Primary or secondary male sexual dysfunction. (2) Male puberty retardation. (3) Palliative treatment of advanced breast cancer in postmenopausal women.
Manufacturer:
Shanghai CP GENERAL Pharmaceutical Co., Ltd.
Testosterone Propionate Injection
Indication: (1) Primary or secondary male sexual dysfunction. (2) Male puberty retardation. (3) Palliative treatment of advanced breast cancer in postmenopausal women.
Testosterone Propionate Injection
Indication: 1. Primary or secondary male sexual dysfunction. 2. Male puberty retardation. 3. Palliative treatment of advanced breast cancer in postmenopausal women.
Manufacturer:
Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.
Testosterone Propionate Injection
Indication: 1. Primary or secondary male sexual dysfunction. 2. Male puberty retardation. 3. Palliative treatment of advanced breast cancer in postmenopausal women.
Testosterone Propionate Injection
Indication: 1. Primary or secondary male sexual dysfunction. 2. Male puberty retardation. 3. Palliative treatment of advanced breast cancer in postmenopausal women.
Manufacturer:
GRAND PHARMACEUTICAL(China) Co., Ltd.
Testosterone Propionate Injection
Indication: 1. Primary or secondary male sexual dysfunction. 2. Male puberty retardation. 3. Palliative treatment of advanced breast cancer in postmenopausal women.
Manufacturer:
Henan Kelun Pharmaceutical Co., Ltd.
Testosterone Propionate Injection
Indication: 1. Primary or secondary male sexual dysfunction. 2. Male puberty retardation. 3. Palliative treatment of advanced breast cancer in postmenopausal women.
Manufacturer:
GRAND PHARMACEUTICAL(China) Co., Ltd.
Bismuth Subnitrate
Indication: 1. Primary or secondary male sexual dysfunction. 2. Male puberty retardation. 3. Palliative treatment of advanced breast cancer in postmenopausal women.
Bismuth Subnitrate
Indication: 1. Primary or secondary male sexual dysfunction. 2. Male puberty retardation. 3. Palliative treatment of advanced breast cancer in postmenopausal women.
Manufacturer:
Xilong Scientific Co., Ltd.
Bismuth Subnitrate
Indication: 1. Primary or secondary male sexual dysfunction. 2. Male puberty retardation. 3. Palliative treatment of advanced breast cancer in postmenopausal women.
Manufacturer:
Hunan Xiangyikang Pharmaceutical Co., Ltd.